247 related articles for article (PubMed ID: 17376828)
41. The CVB and etiology of type 1 diabetes.
Drescher KM; Tracy SM
Curr Top Microbiol Immunol; 2008; 323():259-74. PubMed ID: 18357774
[TBL] [Abstract][Full Text] [Related]
42. Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice.
Xia CQ; Peng R; Qiu Y; Annamalai M; Gordon D; Clare-Salzler MJ
Diabetes; 2007 Aug; 56(8):2116-23. PubMed ID: 17496235
[TBL] [Abstract][Full Text] [Related]
43. The role of low avidity T cells in the protection against type 1 diabetes: a modeling investigation.
Khadra A; Santamaria P; Edelstein-Keshet L
J Theor Biol; 2009 Jan; 256(1):126-41. PubMed ID: 18950644
[TBL] [Abstract][Full Text] [Related]
44. [Coxsackievirus B infection and pathogenesis of type 1 diabetes].
Nekoua MP; Mercier A; Vergez I; Morvan C; Mbani CJ; Sane F; Lobert D; Engelmann I; Romond MB; Alidjinou EK; Hober D
Virologie (Montrouge); 2022 DéCembre 01; 26(6):415-430. PubMed ID: 36565260
[TBL] [Abstract][Full Text] [Related]
45. Persistence of residual beta cells and islet autoimmunity during increasing duration of diabetes in NOD mice and experimental approaches toward reversing new-onset disease with bioactive peptides.
Reddy S; Cheung CC; Chai RC; Rodrigues JA
Ann N Y Acad Sci; 2008 Dec; 1150():171-6. PubMed ID: 19120289
[TBL] [Abstract][Full Text] [Related]
46. Human clonal CD8 autoreactivity to an IGRP islet epitope shared between mice and men.
Unger WW; Pinkse GG; Mulder-van der Kracht S; van der Slik AR; Kester MG; Ossendorp F; Drijfhout JW; Serreze DV; Roep BO
Ann N Y Acad Sci; 2007 Apr; 1103():192-5. PubMed ID: 17376840
[TBL] [Abstract][Full Text] [Related]
47. Enteroviruses, hygiene and type 1 diabetes: toward a preventive vaccine.
Drescher KM; von Herrath M; Tracy S
Rev Med Virol; 2015 Jan; 25(1):19-32. PubMed ID: 25430610
[TBL] [Abstract][Full Text] [Related]
48. beta cell-specific CD4+ T cell clonotypes in peripheral blood and the pancreatic islets are distinct.
Li L; He Q; Garland A; Yi Z; Aybar LT; Kepler TB; Frelinger JA; Wang B; Tisch R
J Immunol; 2009 Dec; 183(11):7585-91. PubMed ID: 19917704
[TBL] [Abstract][Full Text] [Related]
49. Plasmacytoid dendritic cells in autoimmune diabetes - potential tools for immunotherapy.
Nikolic T; Welzen-Coppens JM; Leenen PJ; Drexhage HA; Versnel MA
Immunobiology; 2009; 214(9-10):791-9. PubMed ID: 19628297
[TBL] [Abstract][Full Text] [Related]
50. A Coxsackievirus B vaccine protects against virus-induced diabetes in an experimental mouse model of type 1 diabetes.
Stone VM; Hankaniemi MM; Svedin E; Sioofy-Khojine A; Oikarinen S; Hyöty H; Laitinen OH; Hytönen VP; Flodström-Tullberg M
Diabetologia; 2018 Feb; 61(2):476-481. PubMed ID: 29151123
[TBL] [Abstract][Full Text] [Related]
51. Virus antibody survey in different European populations indicates risk association between coxsackievirus B1 and type 1 diabetes.
Oikarinen S; Tauriainen S; Hober D; Lucas B; Vazeou A; Sioofy-Khojine A; Bozas E; Muir P; Honkanen H; Ilonen J; Knip M; Keskinen P; Saha MT; Huhtala H; Stanway G; Bartsocas C; Ludvigsson J; Taylor K; Hyöty H;
Diabetes; 2014 Feb; 63(2):655-62. PubMed ID: 24009257
[TBL] [Abstract][Full Text] [Related]
52. Immunological aspects of 'fulminant type 1 diabetes'.
Nagata M; Moriyama H; Kotani R; Yasuda H; Kishi M; Kurohara M; Hara K; Yokono K
Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S99-103. PubMed ID: 17478003
[TBL] [Abstract][Full Text] [Related]
53. IL-10-deficiency unmasks unique immune system defects and reveals differential regulation of organ-specific autoimmunity in non-obese diabetic mice.
Rajagopalan G; Kudva YC; Sen MM; Marietta EV; Murali N; Nath K; Moore J; David CS
Cytokine; 2006 Apr; 34(1-2):85-95. PubMed ID: 16740391
[TBL] [Abstract][Full Text] [Related]
54. Superoxide Production by NADPH Oxidase Intensifies Macrophage Antiviral Responses during Diabetogenic Coxsackievirus Infection.
Burg AR; Das S; Padgett LE; Koenig ZE; Tse HM
J Immunol; 2018 Jan; 200(1):61-70. PubMed ID: 29158420
[TBL] [Abstract][Full Text] [Related]
55. NO-mediated cytotoxicity contributes to multiple low-dose streptozotocin-induced diabetes but not to NOD diabetes.
Yasuda H; Jin Z; Nakayama M; Yamada K; Kishi M; Okumachi Y; Arai T; Moriyama H; Yokono K; Nagata M
Diabetes Res Clin Pract; 2009 Feb; 83(2):200-7. PubMed ID: 19117633
[TBL] [Abstract][Full Text] [Related]
56. Bone marrow is a preferential homing site for autoreactive T-cells in type 1 diabetes.
Li R; Perez N; Karumuthil-Melethil S; Vasu C
Diabetes; 2007 Sep; 56(9):2251-9. PubMed ID: 17596402
[TBL] [Abstract][Full Text] [Related]
57. 'Sensing' autoimmunity in type 1 diabetes.
Tsui H; Razavi R; Chan Y; Yantha J; Dosch HM
Trends Mol Med; 2007 Oct; 13(10):405-13. PubMed ID: 17900987
[TBL] [Abstract][Full Text] [Related]
58. Echovirus infection causes rapid loss-of-function and cell death in human dendritic cells.
Kramer M; Schulte BM; Toonen LW; de Bruijni MA; Galama JM; Adema GJ; van Kuppeveld FJ
Cell Microbiol; 2007 Jun; 9(6):1507-18. PubMed ID: 17298395
[TBL] [Abstract][Full Text] [Related]
59. Enteroviral pathogenesis of type 1 diabetes.
Hober D; Sane F
Discov Med; 2010 Aug; 10(51):151-60. PubMed ID: 20807476
[TBL] [Abstract][Full Text] [Related]
60. The virtual NOD mouse: applying predictive biosimulation to research in type 1 diabetes.
Zheng Y; Kreuwel HT; Young DL; Shoda LK; Ramanujan S; Gadkar KG; Atkinson MA; Whiting CC
Ann N Y Acad Sci; 2007 Apr; 1103():45-62. PubMed ID: 17376834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
